dr. camidge discusses treatment of patients with alk nsclc
Published 5 years ago • 533 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:37
dr. camidge on the alex trial in patients with alk nsclc
-
2:29
dr. ross camidge discusses crizotinib in ros1 rearranged nsclc
-
1:52
dr. camidge on optimal therapy in egfr nsclc
-
1:28
dr. camidge on ap26113 in patients with advanced malignancies
-
1:34
dr. camidge on the alta study of brigatinib in nsclc
-
1:00
dr. camidge on phase i study with azd9291 in nsclc
-
1:19
dr. ross camidge discusses resequencing lung cancer
-
1:35
dr. camidge on low testosterone in patients with alk-positive lung cancer
-
1:09
dr. camidge on crizotinib as a ros1 inhibitor in nsclc
-
1:00
dr. camidge discusses unmet needs in alk lung cancer
-
1:55
dr. d. ross camidge on targeted therapies in adjuvant non-small cell lung cancer
-
4:41
evolving approaches for treating alk-positive nsclc
-
1:15:17
dr ross camidge 1:3:20
-
6:19
ross camidge: brigatinib for adult patients with alk metastatic non-small cell lung cancer
-
1:51
dr. shaw on ldk378 in alk crizotinib-resistant nsclc patients
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc
-
1:53
dr. kelly discusses the treatment of patients with alk nsclc
-
4:31
alk-positive nsclc: alex trial
-
1:35
d. ross camidge discusses the development of a new lung cancer drug